Serum Metal Ion Levels in Patients Who Underwent Cathcart/Corail Hemiarthroplasty for Fractured Neck of Femur
1 other identifier
observational
56
1 country
1
Brief Summary
Elevated serum metal ions are well recognized in metal-on-metal articulations in total hip replacements. The objective of the study is to see if the Cathcart / Corail device implanted during a hemiarthroplasty (replacement of one half of the hip joint) results in elevated serum metal ion levels (cobalt \& chromium) and to see if there is an association between size of Cathcart head used and metal ion levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 6, 2014
CompletedFirst Posted
Study publicly available on registry
June 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedOctober 31, 2019
October 1, 2019
3.8 years
June 6, 2014
October 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in serum metal ion level (Chromium and Cobalt) at year 2
One and two years post surgery
Secondary Outcomes (1)
The association between Oxford Hip Score, head diameter and metal ion levels.
up to two years post surgery
Study Arms (1)
No treatment
Eligibility Criteria
100 patients receiving a Cathcart Hemiarthroplasty for intracapsular fractured neck of femur at the Royal Berkshire Hospital
You may qualify if:
- All patients who received a Cathcart Hemiarthroplasty and are able to attend for blood testing and complete a questionnaire (Oxford Hip Score).
You may not qualify if:
- Those patients too frail or who now live too far away to attend for blood testing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Royal Berkshire NHS Foundation Trustlead
- DePuy Internationalcollaborator
Study Sites (1)
Royal Berkshire NHS Foundation Trust
Reading, Berkshire, RG15AN, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Andrade, FRCS MSc
Royal Berkshire NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2014
First Posted
June 13, 2014
Study Start
June 1, 2014
Primary Completion
April 1, 2018
Study Completion
December 1, 2019
Last Updated
October 31, 2019
Record last verified: 2019-10